Linagliptin Impurity 17
| Product Name | Linagliptin Impurity 17 |
|---|---|
| Alternate Names | Linagliptin Impurities, Impurities of Linagliptin |
| CAT No. | CS-EO-01092 |
| CAS No. | 2489212-72-6 |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 957.10 g/mol |
| Mol. For. | C₅₁H₅₆N₁₆O₄ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Linagliptin |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Linagliptin Impurity 17 is a chemical compound that is commonly used in research and development of pharmaceutical products. It is typically used as a reference standard in analytical testing to determine the purity and potency of linagliptin, a medication used to treat type 2 diabetes.
Chemically, Linagliptin Impurity 17 is known as 2-[(4-methylpiperazin-1-yl)methyl]-4-(2-methylpropoxy)benzonitrile. It is a white to off-white crystalline powder with a molecular weight of 338.45 g/mol. It is soluble in common organic solvents like methanol, acetonitrile, and dichloromethane.
In pharmaceutical research, Linagliptin Impurity 17 is used as a quality control reference standard to ensure that the linagliptin medication being developed or produced is of the highest purity and quality. This is important because impurities can affect the efficacy and safety of a medication.
It is also used in the development of new analytical methods for the detection and quantification of linagliptin in biological samples. This helps in determining the optimal dosage of the medication for patients.
Overall, Linagliptin Impurity 17 plays a crucial role in the development and quality control of linagliptin medication, which is important in the treatment of type 2 diabetes.
Get an Instant Quote
Related Compounds
Linagliptin impurity S | Linagliptin Impurity 30 | Linagliptin impurity E | Linagliptin Impurity 117 | Linagliptin-d9 | Linagliptin Ethyldimer | Linagliptin Impurity 35 | Linagliptin Impurity W | Linagliptin Impurity 4 | Linagliptin impurity J | N-(6-Amino-1,2,3,4-tetrahydro-1-methyl-2,4-dioxo-5-pyrimidinyl)formamide | Linagliptin Impurity 2 | Linagliptin Diene Impurity | Linagliptin Impurity 1 | Linagliptin Dimer Impurity | Linagliptin impurity P | Linagliptin Impurity 41 | Linagliptin impurity K | Linagliptin N-Amino Acyl Impurity | Linagliptin Impurity N | Desbutyl N-nitroso Linagliptin impurity 16 | Linagliptin Impurity 43 | Linagliptin Impurity 75 HCl salt | Linagliptin N-Acetyl Impurity | Linagliptin Hydroxy Impurity | Linagliptin tert-butyl carbamate | Linagliptin impurity C | Linagliptin Impurity 76 TrisHCl salt | Linagliptin Impurity T | Linagliptin Impurity 38 | N-Formyl Linagliptin | Linagliptin Impurity 9 | Linagliptin Impurity 5 | Linagliptin Impurity 106 | Linagliptin Impurity 29 | Linagliptin Impurity 36 | Linagliptin impurity V | Linagliptin impurity R | Linagliptin Dimer impurity (N-C-C-C Dimer) | Linagliptin impurity H | Linagliptin Impurity-VII | Linagliptin Methyldimer | Linagliptin Impurity 37 | Linagliptin Dimer Impurity | Linagliptin Impurity 42 | Linagliptin Impurity G | Linagliptin Pentahydroxy Impurity | Linagliptin impurity 115 | Linagliptin Impurity 25 | Hydroxy Methyl Linagliptin | Linagliptin Impurity II | Linagliptin Impurity I | N-Hydroxy Linagliptin | Desbutyl N-nitroso Linagliptin Impurity 52 | Linagliptin Impurity D | Linagliptin impurity F | Linagliptin Impurity Q | Linagliptin impurity B | Linagliptin impurity Y | N-nitroso linagliptin impurity 92 | Linagliptin Glycosamine | Linagliptin Impurity 51 | Linagliptin Dimer Impurity 4 | Linagliptin Impurity 49 | Desalkyl N-nitroso Linagliptin | N-Phthalimide-linagliptin | Linagliptin impurity M | Desmethyl N-nitroso Linagliptin | Linagliptin impurity 14 | Linagliptin Impurity 3 |